Today: 11 June 2026
Browse Category

SHA:688396 18 January 2026 - 2 February 2026

China Resources Microelectronics (688396) stock slides as filing flags 2026 price rises, SiC push

China Resources Microelectronics (688396) stock slides as filing flags 2026 price rises, SiC push

China Resources Microelectronics’ Class A shares fell 3.6% to 61.50 yuan in Shanghai by 0953 GMT+8, underperforming the SSE Composite Index, which slipped 0.7%. Rival chipmakers Montage Technology and GigaDevice Semiconductor gained 2% and 7%. Investors await the company’s April 25 earnings report for evidence that recent price hikes and product upgrades are improving margins.
2 February 2026
···
China Resources Microelectronics stock price in focus: filing flags 2026 revenue lift, higher margins and SiC push

China Resources Microelectronics stock price in focus: filing flags 2026 revenue lift, higher margins and SiC push

China Resources Microelectronics shares closed at 63.77 yuan in Shanghai, down 0.02% after trading between 61.50 and 64.65. The chipmaker forecast “positive” revenue and margin growth for 2026, citing demand in autos, energy storage, and AI. Management highlighted plans to expand 12-inch wafer capacity and boost third-generation semiconductor output. Shares have risen about 20.6% since January 1.
1 February 2026
···
China Resources Microelectronics (688396) stock jumps 13% near 52-week high as China chip trade heats up

China Resources Microelectronics (688396) stock jumps 13% near 52-week high as China chip trade heats up

China Resources Microelectronics A-shares closed up 13.04% at 68.20 yuan in Shanghai Friday, with 58.24 million shares traded and turnover of 3.79 billion yuan. The surge followed shareholder approval of a 2026 related-party transaction plan and changes to governance rules. A storage-chip index hit a record high, while DRAM and NAND prices are forecast to jump sharply in Q1 2026.
18 January 2026
···

Stock Market Today

  • Ideaya Biosciences Stock Drops 10% Amid $300M Fundraising Despite Bullish Outlook
    June 10, 2026, 10:30 PM EDT. Shares of Ideaya Biosciences ($IDYA) fell 10% to around $27 following the announcement of a $300 million stock offering priced at $27 per share, diluting existing shareholder value. The biotech firm had surged 13% earlier due to promising oncology trial results presented at ASCO. Analysts from Citizens reaffirmed a Market Outperform rating and a $45 target, citing robust pipeline developments and collaborations, including a deal with Roche on a novel oncology drug combination. Positive clinical data showed a 37% response rate in uveal melanoma, substantially outperforming standard care. The cash raise aims to advance multiple cancer trials, ensuring a solid financial runway despite near-term stock pressure from dilution.

Latest articles

Tech stocks slide after hours, Oracle’s AI spending draws focus

Tech stocks slide after hours, Oracle’s AI spending draws focus

11 June 2026
Semiconductor stocks plunged 3.6%, dragging the S&P 500 technology sector into correction territory—down 11% from its June 2 record—as investors punished AI-linked companies like Oracle and Super Micro Computer for heavy spending and capital raises, signaling a shift in risk appetite amid rising inflation and escalating U.S.-Iran tensions.
Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Go toTop